| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |